In the spirit of this thread, how about n=12?

First 78 Last

Share
Profile

Follow
n00bmasta

1,240 Posts.

141

03/05/20

15:13

Post #: 44406420
Share

Originally posted by imback: ↑

Spot on. McDoc appeared to be fairly new to both his own industry and investing. Stem cell treatment is such a specialized area of medicine that his opinions were next to worthless in terms of additional insights. Any long term investor here who has done their research would have a significantly better understanding of the issues involved in this area of medicine. If anyone thinks about their own profession, they would be the first to admit their area of specialty does not mean they have any significant insights of another area of specialty on that profession. Yes, the professional training gives a great springboard to further research and understand another specialty but that requires significant effort.

As data driven investors/researchers we won't take into account a N=1 ICU dr/intern opinion when there are plenty of published papers involving thousands of patients. There are also plenty of published papers in stem cell studies by experts in that field. That is the basis hopefully investors are making decisions along with the various analyst reports which have attempted to understand the market size, MSB portion of that market and that corresponding revenue over the short/medium/long term based on some probabilistic estimations.

And unfortunately, I have had similar experiences with you to both drs and emergency room drs. If I am not with my family in those emergency room situations and asking questions and pointing out my own observations, I know 100% that the outcome could have been significantly different. These guys all do best within their ability to cope with the day to day grind but often it is the best and most conscientious which don't last due to their desire to absolutely maximise patient treatment in a profession which cannot work that way for every patient. I have plenty of dr mates and I know the difference in attention/analysis/research/treatment their own family and friends get compared to the general public, unless you have plenty of $$ to pay for the very best.

Expand

In the spirit of this thread, how about n=12?

MSB Price at posting: $3.23 Sentiment: Buy Disclosure: Held
Upvote

0 Great analysis

Reply

Top Stories

I88

Infini hits "stunning" uranium assays with grades over 1% from soil at Portland Creek

Week 26 Wrap: Cerberus of inflation barks – rents, electricity & fuel – and world watches two elders bicker

ASX Market Open: Futures down almost 0.25% on negative data from China

TYP

Tryptamine Therapeutics completes maiden dosing of IV psilocin – a global first

SS1

Sun Silver gets that drill to thrill feeling from high grade hits at Maverick Spring

There are more pages in this discussion • 75 more messages in this thread...

First 78 Last

Add MSB (ASX) to my watchlist

(20min delay)
Last 94.8¢		Change -0.043(4.29%)		Mkt cap ! $1.096B

Open	High	Low	Value	Volume
$1.01	$1.01	94.8¢	$2.219M	2.277M

Buyers (Bids)

No.	Vol.	Price($)
10	51775	94.5¢

Sellers (Offers)

Price($)	Vol.	No.
95.0¢	59501	8

View Market Depth

No.	Vol.	Price($)
14	82336	0.950
10	62389	0.945
14	156493	0.940
8	628377	0.935
9	59981	0.930

Price($)	Vol.	No.
0.955	125480	16
0.960	109867	12
0.965	123446	9
0.970	53399	8
0.975	151115	6

Last trade - 10.58am 01/07/2024 (20 minute delay)

MSB (ASX) Chart

In the spirit of this thread, how about n=12?

Infini hits "stunning" uranium assays with grades over 1% from soil at Portland Creek

Week 26 Wrap: Cerberus of inflation barks – rents, electricity & fuel – and world watches two elders bicker

ASX Market Open: Futures down almost 0.25% on negative data from China

Tryptamine Therapeutics completes maiden dosing of IV psilocin – a global first

Sun Silver gets that drill to thrill feeling from high grade hits at Maverick Spring

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

In the spirit of this thread, how about n=12?

Top Stories

Infini hits "stunning" uranium assays with grades over 1% from soil at Portland Creek

Week 26 Wrap: Cerberus of inflation barks – rents, electricity & fuel – and world watches two elders bicker

ASX Market Open: Futures down almost 0.25% on negative data from China

Tryptamine Therapeutics completes maiden dosing of IV psilocin – a global first

Sun Silver gets that drill to thrill feeling from high grade hits at Maverick Spring

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News